AstraZeneca Crestor, Exanta Promotions Will Focus On Dosing Advantages
Executive Summary
One of AstraZeneca's promotional messages for its statin Crestor (rosuvastatin) will likely focus on the ability of the 10 mg dose to achieve target cholesterol levels without the need for up-titration
You may also be interested in...
AstraZeneca Exanta Liver Safety Is Key Approval Issue, Company Says
AstraZeneca's discussions with FDA over the safety profile of its investigational anticoagulant Exanta will center on elevated liver enzyme levels reported during clinical trials
AstraZeneca Exanta Liver Safety Is Key Approval Issue, Company Says
AstraZeneca's discussions with FDA over the safety profile of its investigational anticoagulant Exanta will center on elevated liver enzyme levels reported during clinical trials
AstraZeneca Crestor 10 mg Fixed Starting Dose Supported By Committee
Dosing for AstraZeneca's statin Crestor in the general population should start with a fixed dose of 10 mg, FDA's Endocrinologic & Metabolic Drugs Advisory Committee recommended July 9